Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6024.5000 63.50 (1.07%)
NSE Aug 13, 2025 10:19 AM
Volume: 58,325
 

logo
Divi's Laboratories Ltd.
24 Jul 2017
6024.50
1.07%
buy
by HDFC Securities
HDFC Securities
Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter. Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter.
 
Number of FII/FPI investors increased from 922 to 990 in Jun 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended
Market opens higher, Jindal Steel & Power's Q1 net profit grows 11.5% YoY to Rs 1,494 crore
Trendlyne Marketwatch | 13 Aug 2025, 10:01AM
Five stocks to buy from analysts this week - August 12, 2025
The Baseline | 12 Aug 2025, 05:13PM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022